← FDA DRUG APPROVALS

FDA ANDA · ANDA076044

POTASSIUM CHLORIDE

Sponsor: NESHER PHARMS

APPLICATION
ANDA076044
TYPE
ANDA
ORIGINAL APPROVAL
2002-04-05
LATEST ACTION
2002-10-02
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 20MEQ · TABLET, EXTENDED RELEASE · ORAL

Approval history

2002-10-02Manufacturing (CMC) · Supplement 1AP
2002-10-02Labeling · Supplement 2AP
2002-04-05OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →